Orexo AB | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK5.09 |
Market Cap |
SEK2.44 B |
Shares Outstanding |
34.67 M |
Public Float |
18.52 M |
Address |
Rapsgatan 7e Uppsala UP 751 05 Sweden |
Employees | - |
Website | http://www.orexo.com |
Updated | 07/08/2019 |
Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. Its focuses on the treatment of opioid dependence. Its pipeline comprises of Zubsolv, Abstral, Edluar, Zubsolv, OX51, OX-MP1, and OX382. |